Biotech Week Boston Awards: Delphia Therapeutics Wins “Boston Highlight” 2024 Award
View
Archive for In The News
GENETIC ENGINEERING NEWS: The Upside Down: Delphia Therapeutics Launches to Treat Cancer with Activation Lethality
View
ENDPOINTS: Biotech vets raise $67M to develop targeted activators for cancer
View
TIMMERMAN REPORT: Delphia Raises $67M to Nudge Cancer Cells Beyond the Red Line
View
ENDPOINTS: For decades, cancer drug developers have focused on inhibition. Now, a GV-backed startup is eyeing activation
View